News tagged with drug companies
Drug industry, nonprofits join forces to fight world's neglected diseases
Nov 11, 2009 |
not rated yet |
0
Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. Those hard-to-treat ...
Can the relationship between doctors and drug companies ever be a healthy one?
Jul 21, 2009 |
5 / 5 (1) |
1
Should the financial ties between doctors and drug companies be completely cut, or are healthy alliances between the two possible with the common aim of improving human health? A debate in this week's PLoS Medicine discus ...
Moves to make more prescription drugs available over the counter won't help patients or doctors
Medicine & Health / Medications
Jan 14, 2009 |
not rated yet |
0
Government plans to make certain prescription-only drugs for common problems available over the counter have overwhelmingly been given the thumbs down by healthcare professionals, reveals a survey of readers of the influential ...
Drug marketing techniques may be risking patient safety
Dec 03, 2008 |
5 / 5 (1) |
0
With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients' safety is being compromised, warns a study published on bmj.com today.
Search results for drug companies
Discovery leads to effective treatment of painful skin condition
Nov 24, 2009 |
not rated yet |
0
Researchers at Huntsman Cancer Institute, in collaboration with a worldwide group of physicians and scientists, have discovered a remarkable treatment for a rare, yet debilitating, skin condition.
Diabetes surgery summit consensus lays foundation for new field of medicine
Nov 24, 2009 |
5 / 5 (1) |
0
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit ...
Drug ads ineffective for boosting sales, could cost taxpayers: study
Nov 23, 2009 |
not rated yet |
0
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.
Systems biology approach provides insulin resistance insights
Nov 23, 2009 |
5 / 5 (1) |
0
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from ...
High blood pressure easy to miss in children with kidney disease
Nov 20, 2009 |
5 / 5 (1) |
0
Spot blood pressure readings in children with chronic kidney disease often fail to detect hypertension - even during doctor's office visits — increasing a child's risk for serious heart problems, according to research from ...
The court will now call its expert witness: the brain
Medicine & Health / Neuroscience
Nov 20, 2009 |
not rated yet |
0
(PhysOrg.com) -- Will advances in neuroscience make the justice system more accurate and unbiased? Or could brain-based testing wrongly condemn some and trample the civil liberties of others? The new field ...
Dispensing prescription drugs in 3-month supplies reduces drug costs by a third
Nov 20, 2009 |
5 / 5 (1) |
0
Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University ...
Future bright for Microsoft cloud computing, server president says
Nov 19, 2009 |
not rated yet |
1
All this week at the Professional Developers Conference, Microsoft has talked about cloud computing, what many consider the next frontier. Bob Muglia, president of the company's Server and Tools business, sat down to talk ...
ICT fails to accelerate drug approvals
Nov 19, 2009 |
not rated yet |
0
Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, ...
Promising pharmaceutical agents emerge as sports doping products
Medicine & Health / Medications
Nov 19, 2009 |
not rated yet |
0
Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their ...
List of search results for drug companies
